Upcoming Webinars

AsIAm is delighted to host an online workshop series as a Grant-Funded member with the Disability Participation and Consultation Network. These workshops focus on the topic of self-advocacy and advocating your rights within the Autistic community and using effectively engaging with your community and with policymakers as a tool for advocating for your rights. These are four sessions which will cover the same content. Our fourth and final session for 2023 will take place on Thursday 16th November from 7:00pm - 8:30pm, online over Zoom. These workshops will be led by Dr. Vivian Rath and Dr. Mary Quirke and will cover: An introduction to advocacy, activism and lobbying and how they work How tools such as the UN Convention on the Rights of Persons with Disabilities can support you or your loved one to advocate for your rights How to organise campaigns How to identify and include like-minded people and organisations in campaigns Engaging with policymakers and Looking after yourself when taking part in campaigns Registration for these workshops is free. To register for this webinar and for more information, please visit our events page on AsIAm.ie. This webinar is part of AsIAm's work as Grant-Funded Member of the Disability Participation and Consultation Network and is proudly supported by the Department of Children, Equality, Disability, Integration and Youth.

In this informative presentation, we will delve into the world of accessible Word documents, exploring the key principles, techniques, and tools needed to make your documents inclusive and user-friendly. Join us and take the first step towards creating content that is inclusive, compliant, and enhances the user experience for everyone.

Ever wondered how much states spend on programs and services for children? Join us for a webinar on November 16 at 2 p.m. EST where we will share national trend data about how states use funding to support children and youth from cradle to career. Speakers include Elizabeth Gaines, Amelia Vaughn, Kiley Bednar, Stephanie Hogenson, and Joe DiCostanzo.

Today’s pharmaceutical industry is demanding more flexibility in manufacturing. Faced with rapidly evolving patient needs and relentless pressure to bring new drugs to market fast, companies must find ways to swiftly adapt, scale and optimize their production processes. But automation systems are traditionally rigid and expensive to change. To address this growing challenge, the manufacturing facility of the future is modular, using 'plug-and-play' technology to deliver greater versatility without increasing costs or compromising quality. In this webinar, you will find out how modular production based on this groundbreaking new standard is changing the industry for the better. You will also hear from Sebastian Härtner, Lead of Future Manufacturing for Life Science and Chemicals at EMD Electronics (a division of Merck KGaA, Darmstadt, Germany). Sebastian will introduce how these flexible manufacturing practices were implemented at one facility and what they have accomplished as a result. Key learning objectives: Why pharmaceutical companies need flexibility in manufacturing, How modularity is achieved using the Module Type Package (MTP) standard from NAMUR NE 148, How a flexible approach makes planning easier for everything from physical connections to IT/OT cybersecurity, Who is already leveraging modular production, and how it is transforming their business.

Reddy & Neumann, P.C. invites you to join our FREE Webinar “Keeping Your F1 Status: A Comprehensive Guide to CPT, OPT, and Beyond” on Thursday, November 16, 2023, from 1:00pm to 2:00pm Central Time. Maintaining F-1 status is essential for international students to legally study and engage in practical training opportunities in the United States. This webinar will outline the key aspects of F-1 status maintenance, including CPT, OPT, STEM OPT extension, and cap-gap extension. This webinar is designed for F-1 international students and will cover a range of crucial topics...

Mitigate Your Risk with Six Steps and New CyberArk HAR Tool. On October 20th, identity management platform Okta disclosed that its support case management system was breached by a threat actor using stolen credentials. The threat actor then launched downstream attacks to Okta’s customers, including 1Password, BeyondTrust and Cloudflare. This type of breach is the latest example in a long line of attacks using compromised or misused identity data – and it certainly won’t be the last. While these types of attacks don’t discriminate and can happen at any time, there are lessons to be learned and steps that can be taken by organizations to mitigate the risk of a breach. Join CyberArk resident experts, Khizar Sultan and Andy Thompson, as they deconstruct the events of this latest breach and share strategies your organization can take to mitigate the risks of identity attacks using strong security processes and operational procedures. Don't miss this opportunity to acquire valuable insights to strengthen your organization's cyber preparedness. Join us for this informative webinar and fortify your defenses against identity threats. Register today!

Understand diabetes and the connection to Covid autoimmunity as it relates to both infection and vaccination.

Integration of Spyder Checkr Video into the Black Magic Da Vinci Resolve colour workflow with Sam Nash.

Thank you for your interest in our event: Time Well Spent: Session 3: Certification and Decertification. Thursday, November 16, 2023, 2:00 p.m. to 2:30 p.m. Eastern 1:00 p.m. to 1:30 p.m. Central 12:00 p.m. to 12:30 p.m. Mountain 11:00 a.m. to 11:30 a.m. Pacific. Please enter your information and select Submit. (*) Required Fields

Windtree Therapeutics, Inc. is advancing late-stage interventions for acute cardiovascular disorders to treat patients in moments of crisis. Using new scientific and clinical approaches, Windtree is developing a multi-asset franchise anchored around compounds with an ability to activate SERCA2a, with lead candidate, istaroxime, being developed as a first-in-class treatment for cardiogenic shock. Windtree's heart failure platform includes follow-on oral pre-clinical SERCA2a activator assets as well. Included in Windtree's portfolio is rostafuroxin, a novel precision drug product targeting the treatment resistant hypertension disease state for patients with certain genetic profiles.